Gemcitabine-Induced Acute Coronary Syndrome: A Case Report

被引:9
作者
Ozturk, Banu [1 ]
Tacoy, Gulten [2 ]
Coskun, Ugur [1 ]
Yaman, Emel [1 ]
Sahin, Giray [1 ]
Buyukberber, Suleyman [1 ]
Yildiz, Ramazan [1 ]
Kaya, Ali O. [1 ]
Topal, Salih [2 ]
Ozdemir, Murat [2 ]
Benekli, Mustafa [1 ]
机构
[1] Gazi Univ, Sch Med, Dept Med Oncol, TR-06500 Ankara, Turkey
[2] Gazi Univ, Sch Med, Dept Cardiol, TR-06500 Ankara, Turkey
关键词
Gemcitabine; Coronary syndrome; Left bundle-branch block; ACUTE MYOCARDIAL-INFARCTION; PHASE-II; 5-FLUOROURACIL; THERAPY; CANCER;
D O I
10.1159/000163051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To report a case of metastatic leiomyosarcoma, in which a patient developed chest pain accompanied by acute left bundle-branch block (LBBB) after gemcitabine infusion. Clinical Presentation and Intervention: A 59-year-old woman admitted with bilateral pulmonary nodules had classic risk factors for coronary heart disease and coronary stenosis as demonstrated by previous coronary angiography. She was treated with gemcitabine infusion, and 30 min later she experienced severe chest pain accompanied by acute LBBB confirmed by ECG. We suspected gemcitabine-induced coronary vasospasm exacerbated by the preexisting coronary artery disease as the cause of the acute coronary syndrome. The patient was subsequently treated with antianginal therapy and percutaneous coronary intervention. Her chest pain resolved and LBBB disappeared. She was discharged 2 days later without any further cardiac events. No additional cancer therapy was given and she died 5 months later, due to disease progression. Conclusion: This case showed that chemotherapeutic agents must be administered with intensive cardiac monitoring especially in patients with cardiac disease and well-known risk factors to prevent the development of cardiac complications, despite an agent not being known to be 'cardiotoxic'. Copyright (C) 2008 S. Karger AG, Basel
引用
收藏
页码:76 / 80
页数:5
相关论文
共 50 条
  • [31] Gemcitabine-induced hemolytic uremic syndrome in ovarian carcinoma
    Nishant Kalra
    Rahul Kad
    Sayed Osama
    International Journal of Clinical Oncology, 2007, 12 : 385 - 387
  • [32] Gemcitabine-induced hemolytic uremic syndrome in ovarian carcinoma
    Kalra, Nishant
    Kad, Rahul
    Osama, Sayed
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2007, 12 (05) : 385 - 387
  • [33] Gemcitabine-induced radiation recall in the treatment of pancreatic cancer
    Zainon, Wan Mohd Nazri Wan
    Borg, M.
    Higgs, B.
    Yeoh, E.
    Kotasek, D.
    Parnis, F.
    Hillenband, E.
    Hamzah, S.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2009, 5 (01) : 17 - 23
  • [34] Delayed Gemcitabine-Induced Posterior Reversible Encephalopathy Syndrome
    Schaub, John R.
    Tang, Shou-Ching
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2021, 361 (06) : 795 - 798
  • [35] Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case report
    Anubha Bharthuar
    Lori Egloff
    Joanne Becker
    Marina George
    James W. Lohr
    George Deeb
    Renuka V. Iyer
    Cancer Chemotherapy and Pharmacology, 2009, 64
  • [36] Gemcitabine-Induced Pseudocellulitis in a Patient With Recurrent Lymphedema: A Case Report and Review of the Current Literature
    Curtis, Susanna
    Hong, Simon
    Gucalp, Rasim
    Calvo, Manuela
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (01) : E321 - E323
  • [37] Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease
    Turco, Celia
    Jary, Marine
    Kim, Stefano
    Moltenis, Melanie
    Degano, Bruno
    Manzoni, Philippe
    Nguyen, Thierry
    Genet, Bruno
    Rabier, Marie-Blanche Valnet
    Heyd, Bruno
    Borg, Christophe
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2015, 9 : 75 - 79
  • [38] Is Therapeutic Plasma Exchange Indicated for Patients with Gemcitabine-Induced Hemolytic Uremic Syndrome?
    Gore, Ethan McCaleb
    Jones, Benjamin Scott
    Marques, Marisa B.
    JOURNAL OF CLINICAL APHERESIS, 2009, 24 (05) : 209 - 214
  • [39] Eculizumab in the Treatment of Gemcitabine-Induced Atypical Hemolytic Uremic Syndrome
    Azad, Farhan
    Miranda, Clive J.
    Al Amin
    Hadwani, Ruhi
    Gravina, Matthew
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
  • [40] Gemcitabine-induced supraventricular tachycardia
    Tayer-Shifman, Oshrat E.
    Rottenberg, Yakir
    Shuvy, Mony
    TUMORI JOURNAL, 2009, 95 (04): : 547 - 549